Interplay between endothelin and erythropoietin in Astroglia: The role in protection against hypoxia

International Journal of Molecular Sciences

Volumn 15, Issue 2, 2014, Pages 2858-2875

  Schäfer, Richard ^a,b   Mueller, Lars ^b   Buecheler, Reinhild ^b,d   Proksch, Barbara ^b   Schwab, Matthias ^b,c   Gleiter, Christoph H ^b   Danielyan, Lusine ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^d Medizinischer Dienst der Krankenversicherung MDK Baden Wuerttemberg   (Germany)

Author keywords

Aging; Astroglia; Endothelin; Endothelin receptor type A antagonist; Erythropoietin; Hypoxia; Neuroprotection

Indexed keywords

CYCLO (DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN A RECEPTOR; ERYTHROPOIETIN; MESSENGER RNA; UNCLASSIFIED DRUG; CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN 1; ERYTHROPOIETIN RECEPTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; MACROGLIA; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BLOCKING; AGONISTS; ANIMAL; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; UPREGULATION; WISTAR RAT;

ANIMALS; ASTROCYTES; CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIN-1; ERYTHROPOIETIN; HUMANS; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER; UP-REGULATION;

EID: 84894235349     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15022858     Document Type: Article

References (60)

1. Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y.; Yazaki, Y.; Goto, K.; Masaki, T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 32, 411-415.
2. Gandhi, C.R.; Nemoto, E.M.; Watkins, S.C.; Subbotin, V.M. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats. Liver 1998, 18, 39-48.
3. Sakurai, T.; Yanagisawa, M.; Inoue, A.; Ryan, U.S.; Kimura, S.; Mitsui, I.; Goto, K.; Masaki, T. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Commun. 1991, 175, 44-47.
4. Boulanger, C.; Luscher, T.F. Release of from the porcine aorta. Inhibition by endotheliumderived nitric oxide. J. Clin. Investig. 1990, 85, 587-590.
5. Lin, H.Y.; Kaji, E.H.; Winkel, G.K.; Ives, H.E.; Lodish, H.F. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc. Natl. Acad. Sci. USA 1991, 88, 3185-3189.
6. Simonson, M.S. Endothelins: Multifunctional renal peptides. Physiol. Rev. 1993, 73, 375-411.
7. Kobari, M.; Fukuuchi, Y.; Tomita, M.; Tanahashi, N.; Konno, S.; Takeda, H. Dilatation of cerebral microvessels mediated by endothelin ETB receptor and nitric oxide in cats. Neurosci Lett. 1994, 176, 157-160.
8. Luo, J.; Grammas, P. Endothelin-1 is elevated in Alzheimer's disease brain microvessels and is neuroprotective. J. Alzheimers Dis. 2010, 21, 887-896.
9. + currents by ET-1 in cultured striatal astrocytes. Am. J. Physiol. Cell Physiol. 2001, 281, C1373-C1384.
10. Taberner, O.A.; Giaume, C.; Medina, J.M. Endothelin-1 regulates glucose utilization in cultured astrocytes by controlling intercellular communication through gap junctions. Glia 1996, 16, 187-195.
11. Leonova, J.; Thorleif, T.; Åberg, N.D.; Eriksson, P.S.; Rönnbäck, L.; Hansson, E. Endothelin-1 decreases glutamate uptake in primary cultured rat astrocytes. Am. J. Physiol. Cell Physiol. 2001, 281, C1495-C1503.
12. Sasaki, Y.; Takimoto, M.; Oda, K.; Fruh, T.; Takai, M.; Okada, T.; Hori, S. Endothelin evokes efflux of glutamate in cultures of rat astrocytes. J. Neurochem. 1997, 68, 2194-2200.
13. 2+ signaling. Am. J. Physiol. Cell Physiol. 1999, 277, C616-C627.
14. Giaume, C.; Cordier, J.; Glowinski, J. Endothelins inhibit junctional permeability in cultured mouse astrocytes. Eur. J. Neurosci. 1992, 4, 877-881.
15. Venance, L.; Stella, N.; Glowinski, J.; Giaume, C. Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. J. Neurosci. 1997, 17, 1981-1992.
16. Ehrenreich, H.; Anderson, R.W.; Ogino, Y.; Rieckmann, P.; Costa, T.; Wood, G.P.; Coligan, J.E.; Kehrl, J.H.; Fauci, A.S. Selective autoregulation of endothelins in primary astrocyte cultures: Endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol. 1991, 3, 135-141.
17. Ehrenreich, H.; Costa, T.; Clouse, K.A.; Pluta, R.M.; Ogino, Y.; Coligan, J.E.; Burd, P.R. Thrombin is a regulator of astrocytic endothelin-1. Brain Res. 1993, 600, 201-207.
18. Kleeberg, J.; Petzold, G.C.; Major, S.; Dirnagl, U.; Dreier, J.P. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H1339-H1346.
19. Agnati, L.F.; Zoli, M.; Benfenati, F.; Bagini, G.; Zini, I.; Hallstrom, A.; Ungerstedt, U.; Toffano, G.; Fuxe, K. A new model of focal brain ischemia based on the intracerebral injection of endothelin-1. Ital. J. Neurol. Sci. 1991, 12, 49-53.
20. Gartshore, G.; Patterson, J.; Macrae, I.M. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp. Neurol. 1997, 147, 353-360.
21. Sato, M.; Noble, L.J. Involvement of the endothelin receptor subtype A in neuronal pathogenesis after traumatic brain injury. Brain Res. 1998, 809, 39-49.
22. Ehrenreich, H.; Nau, T.R.; Dembowski, C.; Hasselblatt, M.; Barth, M.; Hahn, A.; Schilling, L.; Siren, A.L.; Bruck, W. Endothelin B receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience 2000, 95, 993-1001.
23. Kohzuma, M.; Kataoka, Y.; Koizumi, S.; Shibaguchi, H.; Nakashima, M.N.; Yamashita, K.; Niwa, M.; Taniyama, K. ETB receptor involvement in stimulatory and neurotoxic action of endothelin on dopamine neurones. Neuroreport 1994, 5, 2653-2656.
24. Yagami, T.; Ueda, K.; Asakura, K.; Kuroda, T.; Hata, S.; Sakaeda, T.; Kambayashi, Y.; Fujimoto, M. Effects of endothelin B receptor agonists on amyloid b protein (25-35)-induced neuronal cell death. Brain Res. 2002, 948, 72-81.
25. Bachmann, S.; le Hir, M.; Eckardt, K.U. Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J. Histochem. Cytochem. 1993, 41, 335-341.
26. Siren, A.L.; Knerlich, F.; Poser, W.; Gleiter, C.H.; Bruck, W.; Ehrenreich, H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol. (Berl.) 2001, 101, 271-276.
27. Digicaylioglu, M.; Kaul, M.; Fletcher, L.; Dowen, R.; Lipton, S.A. Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage. Neuroreport 2004, 15, 761-763.
28. Sattler, M.B.; Merkler, D.; Maier, K.; Stadelmann, C.; Ehrenreich, H.; Bahr, M.; Diem, R. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ. 2004, 11 (Suppl. 2), S181-S192.
29. Chong, Z.Z.; Li, F.; Maiese, K. Erythropoietin requires NF-. B and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr. Neurovasc. Res. 2005, 2, 387-399.
30. Danielyan, L.; Mueller, L.; Proksch, B.; Kabisch, D.; Weller, M.; Wiesinger, H.; Buniatian, G.H.; Gleiter, C.H. Similar protective effects of BQ123 and erythropoietin on survival of neural cells and generation of neurons upon hypoxic injury. Eur. J. Cell Biol. 2005, 84, 907-913.
31. Esneault, E.; Pacary, E.; Eddi, D.; Freret, T.; Tixier, E.; Toutain, J.; Touzani, O.; Schumann-Bard, P.; Petit, E.; Roussel, S.; et al. Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2008, 28, 1552-1563.
32. Danielyan, L.; Schäfer, R.; Schulz, A.; Ladewig, T.; Lourhmati, A.; Buadze, M.; Schmitt, A.L.; Verleysdonk, S.; Kabisch, D.; Koeppen, K.; et al. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: The critical role of erythropoietin. Cell Death Differ. 2009, 16, 1599-1614.
33. Danielyan, L.; Gembizki, O.; Proksch, B.; Weinmann, M.; Morgalla, M.; Wiesinger, H.; Buniatian, G.H.; Gleiter, C.H. The blockade of endothelin A receptor protects astrocytes against hypoxic injury: Common effects of BQ123 and erythropoietin on the rejuvenation of the astrocyte population. Eur. J. Cell Biol. 2005, 84, 567-579.
34. Slowinski, T.; Schulz, N.; Ruschitzka, F.T.; Quaschning, T.; Bauer, C.; Theuring, F.; Neumayer, H.H.; Gassmann, M.; Hocher, B. Pattern of prepro-endothelin-1 expression revealed by reporter-gene activity in kidneys of erythropoietin-overexpressing mice. Clin. Sci. (Lond.) 2002, 103 (Suppl. 48), 44S-47S.
35. Quaschning, T.; Ruschitzka, F.; Stallmach, T.; Shaw, S.; Morawietz, H.; Goettsch, W.; Hermann, M.; Slowinski, T.; Theuring, F.; Hocher, B.; et al. Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice. FASEB J. 2003, 17, 259-261.
36. Earley, S.; Nelin, L.D.; Chicoine, L.G.; Walker, B.R. Hypoxia-induced pulmonary endothelin-1 expression is unaltered by nitric oxide. J. Appl. Physiol. 2002, 92, 1152-1158.
37. Ritthaler, T.; Göpfert, T.; Firth, J.D.; Ratcliffe, P.J.; Krämer, B.K.; Kurtz, A. Influence of hypoxia on hepatic and renal endothelin gene expression. Pflug. Arch. 1996, 431, 587-593.
38. McWhinnie, R.; Pechkovsky, D.V.; Zhou, D.; Lane, D.; Halayko, A.J.; Knight, D.A.; Bai, T.R. Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292, L278-L286.
39. Banes-Berceli, A.K.; Ketsawatsomkron, P.; Ogbi, S.; Patel, B.; Pollock, D.M.; Marrero, M.B. Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H1291-H1299.
40. Rafiee, P.; Shi, Y.; Su, J.; Pritchard, K.A., Jr.; Tweddell, J.S.; Baker, J.E. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res. Cardiol. 2005, 100, 187-197.
41. Cheng, T.H.; Shih, N.L.; Chen, C.H.; Lin, H.; Liu, J.C.; Chao, H.H.; Liou, J.Y.; Chen, Y.L.; Tsai, H.W.; Chen, Y.S.; et al. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced β-myosin heavy chain gene expression and cardiomyocyte hypertrophy. J. Biomed. Sci. 2005, 12, 123-133.
42. Gonzalez, F.F.; McQuillen, P.; Mu, D.; Chang, Y.; Wendland, M.; Vexler, Z.; Ferriero, D.M. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev. Neurosci. 2007, 29, 321-330.
43. Agnello, D.; Bigini, P.; Villa, P.; Mennini, T.; Cerami, A.; Brines, M.L.; Ghezzi, P. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 2002, 952, 128-134.
44. Ehrenreich, H.; Fischer, B.; Norra, C.; Schellenberger, F.; Stender, N.; Stiefel, M.; Sirén, A.L.; Paulus, W.; Nave, K.A.; Gold, R.; et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007, 130, 2577-2588.
45. Xue, Y.Q.; Zhao, L.R.; Guo, W.P.; Duan, W.M. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 2007, 146, 1245-1258.
46. Rakai, B.D.; Antle, M.C. Lesion size and behavioral deficits afterendothelin-1-induced ischemia are not dependent on time of day. J. Stroke Cerebrovasc. Dis. 2013, 22, 397-405.
47. Ho, M.C.; Lo, A.C.; Kurihara, H.; Yu, A.C.; Chung, S.S.; Chung, S.K. Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J. 2001, 15, 618-626.
48. Morga, E.; Faber, C.; Heuschling, P. Stimulation of endothelin B receptor modulates the inflammatory activation of rat astrocytes. J. Neurochem. 2000, 74, 603-612.
49. Hellwig-Bürgel, T.; Stiehl, D.P.; Wagner, A.E.; Metzen, E.; Jelkmann, W. Review: Hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions. J. Interf. Cytokine Res. 2005, 25, 297-310.
50. Ameln, H.; Gustafsson, T.; Sundberg, C.J.; Okamoto, K.; Jansson, E.; Poellinger, L.; Makino, Y. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J. 2005, 19, 1009-1011.
51. Desai, D.; He, S.; Yorio, T.; Krishnamoorthy, R.R.; Prasanna, G. Hypoxia augments TNF-a-mediated endothelin-1 release and cell proliferation in human optic nerve head astrocytes. Biochem. Biophys. Res. Commun. 2004, 318, 642-648.
52. Danielyan, L.; Lourhmati, A.; Verleysdonk, S.; Kabisch, D.; Proksch, B.; Thiess, U.; Umbreen, S.; Schmidt, B.; Gleiter, C.H. Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF a release. Neurochem. Res. 2007, 32, 1489-1498.
53. Iwasaki, S.; Homma, T.; Matsuda, Y.; Kon, V. Endothelin receptor subtype B mediates autoinduction of endothelin-1 in rat mesangial cells. J. Biol. Chem. 1995, 270, 6997-7003.
54. Khamaisi, M.; Dahan, R.; Hamed, S.; Abassi, Z.; Heyman, S.N.; Raz, I. Role of protein kinase C in the expression of endothelin converting enzyme-1. Endocrinology 2008, 150, 1440-1449.
55. Benigni, A.; Remuzzi, G. Endothelin antagonists. Lancet 1999, 353, 133-138.
56. Nakamura, S.; Naruse, M.; Naruse, K.; Demura, H.; Uemura, H. Immunocytochemical localization of endotheIin in cultured bovine endothelial cells. Histochentistry 1990, 94, 475-477.
57. Nakamura, S.; Naruse, M.; Naruse, K.; Shioda, S.; Nakai, Y.; Uemura, H. Colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axons of the neural lobe of the rat pituitary. Endocrinology 1993, 132, 530-533.
58. Lendahl, U.; Zimmerman, L.B.; McKay, R.D. CNS stem cells express a new class of intermediate filament protein. Cell 1990, 60, 585-595.
59. Lourhmati, A.; Buniatian, G.H.; Paul, C.; Verleysdonk, S.; Buecheler, R.; Buadze, M.; Proksch, B.; Schwab, M.; Gleiter, C.H.; Danielyan, L. Age-dependent astroglial vulnerability to hypoxia and glutamate: The role for erythropoietin. PLoS One 2013, 8, e77182.
60. Ehrenreich, H.; Hasselblatt, M.; Dembowski, C.; Cepek, L.; Lewczuk, P.; Stiefel, M.; Rustenbeck, H.H.; Breiter, N.; Jacob, S.; Knerlich, F.; et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 2002, 8, 495-505.